- Filed
- May 6, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2020 · Mar 31, 2020 | 0 sh |
| Current Liabilities | Q1 2020 · Mar 31, 2020 | $171.98M |
| Current Liabilities | Q1 2020 · Dec 31, 2019 | $144.72M |
| Current Liabilities restated | Q1 2020 · Mar 31, 2019 | $147.26M |
| Total Liabilities | Q1 2020 · Mar 31, 2020 | $2.53B |
| Total Liabilities | Q1 2020 · Dec 31, 2019 | $2.5B |
| Total Liabilities restated | Q1 2020 · Mar 31, 2019 | $2.44B |
| Current Assets | Q1 2020 · Mar 31, 2020 | $78.79M |
| Current Assets | Q1 2020 · Dec 31, 2019 | $66.95M |
| Total Assets | Q1 2020 · Mar 31, 2020 | $4.58B |
| Total Assets | Q1 2020 · Dec 31, 2019 | $4.6B |
| Total Assets restated | Q1 2020 · Mar 31, 2019 | $4.61B |
| Capex | Q1 2020 · Dec 31, 2019 | $16.44M |
| Capex restated | Q1 2020 · Mar 31, 2019 | −$18.68M |
| Capex | Q1 2020 · Dec 31, 2018 | $18.68M |
| Net Income | Q1 2020 · Dec 31, 2019 | $61.78M |
| Net Income restated | Q1 2020 · Mar 31, 2019 | $57.64M |
| Net Income | Q1 2020 · Dec 31, 2018 | $57.64M |
| Operating Cash Flow restated | Q1 2020 · Mar 31, 2019 | $123.15M |
| Cash And Equivalents | Q1 2020 · Mar 31, 2019 | $17.71M |
| Cash And Equivalents | Q1 2020 · Dec 31, 2018 | $18.71M |
| Cash And Equivalents restated | Q1 2020 · Dec 31, 2017 | $18.71M |
| Operating Income restated | Q1 2020 · Mar 31, 2019 | $67.71M |
| Revenue | Q1 2020 · Mar 31, 2019 | $179.49M |